Publications by authors named "L Legros"

Claim this Profile
T
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.
Alexandre Guy, Olivier Mansier, Matisse Decilap, Alexandre Catherineau, Geoffrey Garcia, Laurence Legros

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the impact of VHL exon 2 mutations in erythrocytosis or von Hippel-Lindau disease identified RNA-binding proteins involved in VHL splicing.
Valéna Karaghiannis, Loïc Schmitt, Franck Chesnel, Emilie-Fleur Gautier, Marjorie Leduc, Laurence Legros

Am J Hum Genet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific tools.
Sylvain Moinard, Benjamin Lebecque, Tom Lachaise, Hyacinthe Johnson-Ansah, Charlotte Doublet, Laurence Legros

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, Françoise Boyer, Alberto Santagostino, Laurence Legros

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular signature predicts hematologic evolution in polycythemia vera patients.
Olivier Mansier, Eric Lippert, Lina Benajiba, Dana Ranta, François Girodon, Laurence Legros

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis